1 / 13

Cockayne syndrome

Cockayne syndrome. Background:. Cockayne syndrome:

ida
Télécharger la présentation

Cockayne syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cockayne syndrome

  2. Background: Cockayne syndrome: is a rare and devastating genetic disease. It is present in about 1/100,000 live births. Its inheritance is autosomal recessive. In other words, it occurs if both the father and the mother pass on a damaged gene to the affected child, with the parents themselves having no health problems related to CS, and with 1/4 of the siblings expected to also have CS.

  3. Type: • CS type 1 (CS-A or CKN1): the classic form • CS type 2 (CS-B ): a more severe form with symptoms present at birth • CS type 3: a milder form • xeroderma pigmentosa–Cockayne syndrome (XP-CS)

  4. How to Diagnose (诊断)CS • within the first 2 years of life, growth and development become abnormal. By the time the disease has fully manifested, height, weight, and head circumference are far below the fifth percentile.

  5. The characteristic physical appearance of the aging process. dwarfism(侏儒) with thinning of the skin and hair, sunken eyes, and a stooped standing posture

  6. Lifespan Patients are at risk for postnatal growth failure, pigmentary retinal degeneration, and premature death before adulthood. The oldest CS patient known to Share and Care Cockayne Syndrome Network is in the late 30s. For children born with cataracts, the life expectancy is 12 years, and many CS patients die in infancy. Both the severity of the genetic damage in the individual patient, and the quality of care including ensuring adequate food intake, are important determinants of the lifespan.

  7. pathophysiology Pathologic studies reveal diffuse and extensive demyelination(脱髓鞘) in the central and peripheral nervous systems.

  8. what gene is affected in the CS patient. This includes the CS-A gene, ERCC8 , in about 25% of cases; and the CS-B gene, ERCC6, in about 75% of cases.

  9. CKN1 CKN1 is caused by a defect in the CS type A gene (CSA or ERCC8) located on chromosome 5. Affected persons inherit 2 mutant genes, one from each parent. Cells carrying ERCC8 mutations are hypersensitive to UV light. They do not recover the ability to synthesize RNA after exposure to UV light. In addition, the cells cannot remove and degrade DNA lesions from strands that have active transcription.

  10. Treatment There is no cure for Cockayne syndrome, so threatmentfocuses on relieving symptoms and improving the person’s quality of life. Physical and occupation therapy can help maintain joint function and reduce muscle contractures.

  11. Medical Care: Treatment of patients with CKN1 depends solely on the presenting symptoms. Physical therapy helps prevent contractures and helps maintain ambulation

  12. Activity: Physical therapy is essential to enable patients to avoid joint contractures and to prolong ambulation . Protect: protect himself from sunlight with clothing and sunscreen, to reduce cell damage.

  13. THE END

More Related